Safety and effectiveness of the Colovac anastomosis protection device compared with diverting ileostomy after low anterior resection: protocol for an international, multicentre, prospective, non-randomised comparative study (SAFE-3) - Scorecard - MDSpire
Advertisement
Safety and effectiveness of the Colovac anastomosis protection device compared with diverting ileostomy after low anterior resection: protocol for an international, multicentre, prospective, non-randomised comparative study (SAFE-3)
Clinical Scorecard: Comparative Analysis of the Colovac Anastomosis Protection Device Versus Diverting Ileostomy Following Low Anterior Resection: A Protocol for an International, Multicenter, Prospective, Non-Randomized Study (SAFE-3)
At a Glance
Category
Detail
Condition
Anastomotic leakage after low anterior resection for rectal cancer
Key Mechanisms
Comparison of Colovac device and diverting loop ileostomy for anastomotic protection
Target Population
Patients undergoing low anterior resection for rectal cancer
Care Setting
Multicenter, prospective, non-randomized clinical study
Key Highlights
Study aims to evaluate safety and effectiveness of Colovac device vs diverting ileostomy
Primary endpoints include major complications at 9 months and stoma avoidance at day 10
233 patients to be enrolled across 25 centers in 4 countries
Study approved by ethics committees and monitored for safety
Results will be disseminated through peer-reviewed publications
Guideline-Based Recommendations
Diagnosis
Anastomotic leakage defined as defect at the anastomotic site causing communication between intraluminal and extraluminal compartments
Management
Routine creation of protective diverting loop ileostomy recommended when anastomosis lies within 10 cm of anal verge
Monitoring & Follow-up
Regular review of adverse events and safety data by an independent safety monitoring committee
Risks
Anastomotic leakage associated with morbidity, including peritonitis and sepsis, with mortality around 3.9% at 90 days
Patient & Prescribing Data
Patients undergoing low anterior resection for rectal cancer
Colovac device may provide an alternative to diverting ileostomy, potentially reducing morbidity associated with stoma creation
Clinical Best Practices
Consider selective stoma avoidance strategies after rectal cancer surgery
Utilize the Colovac device for patients requiring anastomotic protection without routine diversion
by Clément Pastier, Patricia Sylla, Sang W Lee, Antonino Spinelli, Niels Komen, John Marks, Joseph Martz, Rebecca Rhee, Justin Maykel, Jorge Marcet, Quentin Denost, Karen Zaghiyan, Jennifer S Davids, Nivedh Paluvoi, David Hiller, Elisabeth C McLemore, Leon Maggiori, Andre D’hoore, Mehraneh D Jafari, Vitaliy Poylin, Christopher Jerome Buzas, Jean-Jaques Tuech, Jérémie H Lefèvre
